Review



goat anti vegfr3 antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems goat anti vegfr3 antibody
    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of <t>Vegfr3-positive</t> lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).
    Goat Anti Vegfr3 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+edar/pmc11949019-281-3-6?v=R%26D+Systems
    Average 93 stars, based on 15 article reviews
    goat anti vegfr3 antibody - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "A single-cell atlas of normal and KRAS G12D -malformed lymphatic vessels"

    Article Title: A single-cell atlas of normal and KRAS G12D -malformed lymphatic vessels

    Journal: JCI Insight

    doi: 10.1172/jci.insight.185181

    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of Vegfr3-positive lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).
    Figure Legend Snippet: ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of Vegfr3-positive lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).

    Techniques Used: Control



    Similar Products

    goat anti vegfr3 antibody  (R&D Systems)
    93
    R&D Systems goat anti vegfr3 antibody
    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of <t>Vegfr3-positive</t> lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).
    Goat Anti Vegfr3 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+edar/pmc11949019-281-3-6?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    goat anti vegfr3 antibody - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    goat 527 anti vegfr3 antibody  (R&D Systems)
    93
    R&D Systems goat 527 anti vegfr3 antibody
    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of <t>Vegfr3-positive</t> lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).
    Goat 527 Anti Vegfr3 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+edar/pm39874106-280-3-7?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    goat 527 anti vegfr3 antibody - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    goat anti edar  (R&D Systems)
    94
    R&D Systems goat anti edar
    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of <t>Vegfr3-positive</t> lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).
    Goat Anti Edar, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+edar/pmc10866703-221-6-8?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    goat anti edar - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    goat anti‐human edar pab (sc‐15290; dilution 1 : 200)  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology goat anti‐human edar pab (sc‐15290; dilution 1 : 200)
    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of <t>Vegfr3-positive</t> lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).
    Goat Anti‐Human Edar Pab (Sc‐15290; Dilution 1 : 200), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+edar/pmc04837237-90-19-29?v=Santa+Cruz+Biotechnology
    Average 90 stars, based on 1 article reviews
    goat anti‐human edar pab (sc‐15290; dilution 1 : 200) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    goat anti edar  (Santa Cruz Biotechnology)
    91
    Santa Cruz Biotechnology goat anti edar
    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of <t>Vegfr3-positive</t> lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).
    Goat Anti Edar, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+edar/pm25366125-49-52-55?v=Santa+Cruz+Biotechnology
    Average 91 stars, based on 1 article reviews
    goat anti edar - by Bioz Stars, 2026-08
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of Vegfr3-positive lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).

    Journal: JCI Insight

    Article Title: A single-cell atlas of normal and KRAS G12D -malformed lymphatic vessels

    doi: 10.1172/jci.insight.185181

    Figure Lengend Snippet: ( A ) Schematics of the Prox1-CreER T2 and Kras LSL-G12D alleles. ( B ) Schematic showing when mice received tamoxifen (50 μg; p.o.). Tissues were collected when mice were 21 days old. ( C ) Low- and high-magnification views of Vegfr3-positive lymphatic vessels in 100-μm-thick lung sections from control and Kras G12D mice. The high-magnification images are of the boxed regions. ( D ) The diameter of lymphatic vessels was significantly greater in Kras G12D mice (25.65 ± 1.070 μm; n = 5) than in control (Ctrl) mice (14.31 ± 0.9752 μm; n = 5). Data are presented as mean ± SEM. **** P < 0.0001 by 2-tailed, unpaired Student’s t test. Scale bars: 500 μm (low magnification) and 50 μm (high magnification).

    Article Snippet: We used a goat anti-Vegfr3 antibody (R&D Systems, AF745; 1:250).

    Techniques: Control